Ian Wilburt Oliva, MD

Targeting accuracy in stereotactic ablative body radiotherapy (SABR) for hepatocellular carcinoma (HCC) is often hindered by the poor soft-tissue visibility of tumors on standard image-guided radiotherapy using kilovoltage (kV) images. However, ~60% of HCC pa...